Clinical Trial Administrator
Pubblicato il 12-10-2026 - Novo Nordisk in Roma
Your impact begins here
As Clinical Trial Administrator, you will keep clinical trials in Italy moving with accuracy and pace. Based in Rome, you will support the local study team from start-up to close-out - managing trial documentation, tracking progress, coordinating vendors and making sure investigator sites' payments are on time. Your work keeps trials compliant and inspection-ready, so new treatments can progress towards the people living with serious chronic diseases who need them.
Your impact begins here
As Clinical Trial Administrator, you will keep clinical trials in Italy moving with accuracy and pace. Based in Rome, you will support the local study team from start-up to close-out - managing trial documentation, tracking progress, coordinating vendors and making sure investigator sites' payments are on time. Your work keeps trials compliant and inspection-ready, so new treatments can progress towards the people living with serious chronic diseases who need them.
What You'll Bring
You pay close attention to detail,
stay organised under pressure and like finding a practical way forward when issues come up. To succeed in this role, you will bring:
- A Master's degree in Life Sciences (preferably Biotechnology, Pharmacy, Chemistry, Biology or CTF)
- A solid understanding of clinical trial phases, regulatory guidelines, Good Clinical Practice (GCP) and ethical considerations.
- Hands-on experience using Clinical Trial Management Systems (CTMS) and other digital tools to manage study documentation and track activities.
- The ability to manage multiple tasks, timelines and stakeholders and to keep milestones on track.
- Strong written and verbal communication skills, and the ability to build good working relationships with internal and external stakeholders.
- Analytical and problem-solving skills to resolve study-related issues and suggest practical improvements.
- Integrity, sound judgement and a strong eye for detail.
- Openness to new digital tools and